Healthcare provider profile · identity verified

Brian L Rodriguez, MD

Family Practice · BERLIN, VT · NPI 1841587839

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	433	119
Lisinopril	Lisinopril	264	68
Omeprazole	Omeprazole	201	55
Amlodipine Besylate	Amlodipine Besylate	177	50
Levothyroxine Sodium	Levothyroxine Sodium	161	43
Tamsulosin Hcl	Tamsulosin Hcl	141	36
Gabapentin	Gabapentin	129	37
Metformin Hcl	Metformin Hcl	123	28
Hydrochlorothiazide	Hydrochlorothiazide	118	36
Fluticasone Propionate	Fluticasone Propionate	108	31
Metoprolol Tartrate	Metoprolol Tartrate	103	25
Sertraline Hcl	Sertraline Hcl	103	23
Simvastatin	Simvastatin	102	27
Losartan Potassium	Losartan Potassium	100	28
Rosuvastatin Calcium	Rosuvastatin Calcium	86	19
Metoprolol Succinate	Metoprolol Succinate	83	21
Pantoprazole Sodium	Pantoprazole Sodium	80	21
Eliquis	Apixaban	73	21
Albuterol Sulfate Hfa	Albuterol Sulfate	68	27
Finasteride	Finasteride	65	18
Pregabalin	Pregabalin	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	16
Furosemide	Furosemide	51	18
Meloxicam	Meloxicam	51	15
Lorazepam	Lorazepam	49	19
Trazodone Hcl	Trazodone Hcl	45	15
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Chlorthalidone	Chlorthalidone	43	13
Famotidine	Famotidine	43	13
Tramadol Hcl	Tramadol Hcl	43	suppressed
Trulicity	Dulaglutide	43	11
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Allopurinol	Allopurinol	38	11
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Atenolol	Atenolol	36	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	12
Januvia	Sitagliptin Phosphate	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Ozempic	Semaglutide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Ibuprofen	Ibuprofen	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Risperidone	Risperidone	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Topiramate	Topiramate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Pulmicort Flexhaler	Budesonide	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Naproxen	Naproxen	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Primidone	Primidone	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Glipizide	Glipizide	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error